Top Markets
#1 Official Trump Official Trump +41.49%
#2 Melania Meme Melania Meme +24.96%
#3 Nockchain Nockchain +24.66%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +21.17%
#5 Mubarak Mubarak +19.32%
#6 EXOD EXOD +18.93%
#7 Unit Pump Unit Pump +16.04%
#8 Pump.fun Pump.fun +16.04%
#9 MowCat MowCat +14.02%
#10 Wrapped POL Wrapped POL +13.94%
Coin of the day
Official Trump Official Trump
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Aeglea BioTherapeutics, Inc. Aeglea BioTherapeutics, Inc.

Aeglea BioTherapeutics, Inc.

AGLE
Rang în acțiuni #23495
Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated... Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating human enzyme therapies for rare metabolic diseases. Their leading candidate, pegzilarginase, a recombinant human Arginase 1, is currently in the pivotal Phase III PEACE trial to assess its safety and effectiveness for treating Arginase 1 deficiency. Furthermore, the company is developing AGLE-177, a polyethylene glycol modified enzyme, which is progressing through Phase I/II clinical trials for homocystinuria. Their early-stage pipeline includes AGLE-325 for cystinuria, along with other ongoing research initiatives. Founded in 2013, the company was initially known as Aeglea BioTherapeutics Holdings, LLC, changing its name to Aeglea BioTherapeutics, Inc. in March 2015. It is based in Austin, Texas.
Preț acțiune
$19.30
Ultima sincronizare: 2023-12-26
Capitalizare de piață
$72.77M
Schimbare (1 zi)
6.22%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Aeglea BioTherapeutics, Inc. (AGLE)

Categorie

Healthcare
Venituri pentru Aeglea BioTherapeutics, Inc. (AGLE)
Venituri în Aug 2026 TTM: 0
Conform celor mai recente rapoarte financiare ale Aeglea BioTherapeutics, Inc., venitul actual al companiei (TTM) este 0. În anul 2026, compania a avut un venit de 0 egal cu venitul din anul 2026, care a fost de 0. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru Aeglea BioTherapeutics, Inc. din 2026 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
Nu sunt suficiente date pentru perioada selectată.
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH